Hologic rings Nasdaq opening bell for 15th time to kick off Breast Cancer Awareness Month


Women’s Health Leader Launches Series of Educational and Outreach Initiatives Focused on Eliminating Racial Disparities in Breast Cancer Screening and Care

MARLBOROUGH, Mass., October 4, 2021– (BUSINESS WIRE) – Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health, today announced that CEO Steve MacMillan will ring the bell of Nasdaq opens on October 4 to mark the start of Breast Cancer Awareness Month.

The ceremony will kick off a series of efforts by Hologic, the company behind the Genius® 3D Mammography ™ Exam and the first Global Women’s Health Index, to raise awareness of the importance of annual mammograms and continue to shed light on inequalities in care, including racial disparities in breast cancer screening.

This initiative comes at a pivotal time, as recent research has shown that globally only 12% of women in 2020 reported having been tested for any type of cancer in the past 12 months.1 In addition, earlier this year, an in-depth study published in the Journal of the American College of Radiology (JACR) found that black women were less likely to have a digital breast tomosynthesis (DBT) exam and less likely to be screened multiple times over a five-year period than white women.2

“Breast Cancer Awareness Month is an opportunity to reflect on the work we have done with our partners to eliminate the disparities in breast cancer screening among black women. While we are proud of the progress we have made, there is still a lot of work to be done before us, ”said MacMillan. “Our commitment to advancing change through education, research and the delivery of care is unwavering because we believe that all women should enjoy the dignity and benefits of early detection of breast cancer. “

After the bell, Hologic will welcome System Screening: A Dialogue on Stigma and Breast Health, a panel discussion with Linda Goler Blount, President and CEO of Black Women’s Health Imperative (BWHI); Mary J. Blige, Grammy Award-winning artist and spokesperson for POWER of Sure; and Dr. Arlene Richardson, chair of the radiology department, Jackson Park Hospital, Chicago, recipient of funding from Hologic’s Project Health Equality. The event will be available live on Hologic’s YouTube channel starting at 11:00 a.m. EDT.

Complementing this essential conversation, the launch of new patient education resources through the POWER of Sure campaign – a joint effort between BWHI and Hologic that examines common barriers to early detection and raises awareness of the importance of annual mammograms. in black women. Campaign spokesperson Mary J. Blige and several prominent black women lend their voices to the campaign, which features a digital multimedia center with resources including common facts and myths about mammography, frequently asked questions about cancer breast screening guidelines; and a list of locations offering breast cancer screening.

Additionally, to reach as many women as possible in October, Hologic has partnered with The Ellen DeGeneres Show and The truth broadcast educational programming and digital content on breast health. The partnership will also include a broadcast fundraising campaign supporting RAD-AID, a nonprofit organization dedicated to ensuring equal access to radiology services for medically underserved communities.

Hologic’s partnership with RAD-AID supports innovative care, radiology, public education and navigation for nurses at multi-regional sites selected by RAD-AID as clinical partners to provide critical screening, diagnostic imaging breast and treatment for women who might otherwise be without it. The sites and facilities under development for this program are located in areas such as the South Side of Chicago, Washington DC, and Seattle / Pacific Northwest, among others.

About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company focused primarily on improving the health and well-being of women through early detection and treatment. For more information on Hologic, visit www.hologic.com.

Hologic, Genius, 3D Mammography, and The Science of Sure are trademarks and / or registered trademarks of Hologic, Inc. and / or its subsidiaries in the United States and / or other countries.

Forward-looking statements

This press release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic products. There can be no assurance that these products will provide the benefits described herein or that these benefits will be reproduced in any particular way with respect to an individual patient, as the actual effect of using the products can only be determined. case by case. -base of cases. In addition, there can be no assurance that these products will be commercially successful or reach the expected level of sales. Hologic expressly disclaims any obligation or commitment to publicly post any update or revision to any such statements presented here to reflect any change in expectations or any change in the events, conditions or circumstances upon which such data or statements are based.

This information is not intended as a product solicitation or promotion where such activities are prohibited. For specific information on products available for sale in a particular country, please contact a local Hologic sales representative or write to [email protected]

SOURCE: Hologic, Inc.

1 hologic.womenshealthindex.com.

2 Alsheik, N., Blount, L., Qiong, Q., Talley, M., Pohlman, S., Troeger, K., Abbey, G., Mango, VL, Pollack, E., Chong, A., Donadio , G., Behling, M., Mortimer, K., & Conant, E. (2021). Results by race in breast cancer screening with digital breast tomosynthesis compared to digital mammography. Journal of the American College of Radiology, 18(7), 906-918. https://doi.org/10.1016/j.jacr.200.12.033

See the source version on businesswire.com: https://www.businesswire.com/news/home/20211002005185/en/


Media contact:
Jane mazur
508.263.8764 (direct)
585.355.5978 (mobile)
[email protected]

Investor contact:
Michael watts
858.410.8588 (direct)
[email protected]

Source link

Leave A Reply

Your email address will not be published.